Bank of America’s Jyong Biotech MENS Stock Holding History

Bank of America’s Portfolio MENS Stock Details MENS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,182	Closed	-$91.6K	–	7227
2025 Q4	$91.6K	Buy	+23,182	New	+$819K	﹤0.01%	5653

Other funds holding MENS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America's MENS Position: Q1 2026 in Review

Bank of America sold out of Jyong Biotech (MENS) in Q1 2026, closing a stake of 23,182 shares — an estimated $91.6K sold.

Bank of America first reported a position in MENS in Q4 2025 and held it in 1 quarter. The position peaked at $91.6K in Q4 2025. 17 funds tracked by Wall St. Rank hold MENS as of Q1 2026.

Bank of America reported no remaining Jyong Biotech position as of Q1 2026 after selling out during the quarter.
Bank of America sold 23,182 Jyong Biotech shares in Q1 2026, an estimated $91.6K.
Bank of America first reported a position in Jyong Biotech in Q4 2025 and held it in 1 quarter.
Bank of America's Jyong Biotech position peaked at $91.6K in Q4 2025.
17 funds tracked by Wall St. Rank held Jyong Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.